Andorra vs Developing regions: Proportion of the target population … measles-containing-vaccine
Andorra
97.0%
in 2024
Developing regions
75.0%
in 2024
Andorra rank
22nd
Developing regions rank
23rd
Proportion of the target population … measles-containing-vaccine over time
- Andorra
- Developing regions
How they compare
Andorra currently reports 97.0% against 75.0% in Developing regions, a difference of 22.0%.
That makes Andorra's figure about 1.3 times Developing regions's.
Across all 18 years both countries report, Andorra has been ahead every year.
Andorra ranks 22nd and Developing regions ranks 23rd of 195 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.7% | 33.3% | 49.3% | Andorra |
| 2010s | 90.2% | 56.0% | 34.2% | Andorra |
| 2020s | 95.8% | 71.0% | 24.8% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Andorra or Developing regions?
- Andorra, at 97.0% against 75.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received between Andorra and Developing regions?
- 22.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Developing regions?
- 18 years are reported by both, from 2007 to 2024.
- How do Andorra and Developing regions rank globally for proportion of the target population who received?
- Andorra ranks 22nd and Developing regions ranks 23rd of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.